NanoViricides, Inc.
PublicNanoViricides, Inc. is now publicly traded
The data on this page reflects NanoViricides, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed Round
Nov 12, 2025
Total Funding Raised
$8.5M
Company Overview
NanoViricides, Inc. operates in Healthcare and is based in the United States. It has raised $8.5M.
NanoViricides, Inc. is a biotechnology company that discovers, develops, and commercializes drugs to combat viral infections.
Sector
Healthcare
AI Layer
Non-AI
NanoViricides, Inc. Comparables
Compare NanoViricides, Inc. with similar companies based on industry and business-model similarity.
No comparables are published for NanoViricides, Inc.. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
NanoViricides, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Nov 12, 2025 | ||||
| Private Placement | Feb 28, 2019 |
For institutional investors. Book with your work email.
NanoViricides, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.